MYOS Corporation (MYOS) Stock: Continues Climbing On Yolked!

0
523
MYOS RENS Technology MYOS Stock News

MYOS Corporation common stock (NASDAQ: MYOS) is having yet another incredibly strong day in the market today, following up on the gains seen yesterday. The gains are ultimately the result of a new product, known as Yolked. Today, we’ll talk about:

  • The product launch;
  • what we’re seeing from MYOS stock as a result; and
  • what we’ll be watching for ahead.

MYOS Announces Product Launch

As mentioned above, MYOS RENS Technology is having an incredibly strong start to the trading session today, following up on yesterday’s announcement. In a press release issued yesterday, the company announced the launch of a new health drink known as Yolked.

The new drink is an all-natural product, featuring Fortetropin, a proprietary bioactive composition that comes from fertillized egg yolk. This helps to build lean muscle.

To make the news better, the company announced that The Vitamin Shoppe will be the first retailer to carry the new product. The product will be featured in 775 retail locations across the United States and online at vitaminshoppe.com starting on December 30, 2018. The product will come with a price tag of $99.99 during the launch.

In a statement, Joseph Mannello, CEO at MYOS, had the following to offer:

We are very pleased to partner with The Vitamin Shoppe®, one of the largest and most respected companies in the industry, whose customers have an overwhelming demand for new, safe, all-natural and effective nutritional supplement products. The Vitamin Shoppe® recognizes that Yolked®, formulated with Fortetropin®, is not only great-tasting and good for you– it is also protein’s perfect partner in that it enables the body to utilize protein more efficiently to build muscle mass and size. Yolked greatly complements the growing protein categories and we believe it will draw additional consumers to the segment.

The above statement was followed up by Mark Hilton, VP of Merchandising at The Vitamin Shoppe. Here’s what he had to say:

When it comes to innovation, we are extremely selective with what we bring to market as it must first resonate with our customers and meet their needs and expectations… We feel that Yolked® will make an excellent addition to our portfolio of offerings as it is a truly unique product that’s clinically proven to increase muscle growth and lean body mass, which are both key components our customers look for when choosing their sports nutrition solutions.

What We’re Seeing From The Stock 

One of the first lessons that we learn when we start to work in the market is that the news leads to moves. In the case of MYOS RENS Technology, the news proved to be overwhelmingly positive. After all, not only is the company launching a new product, upon the launch of that product it will be featured in 775 retail stores across the United States, likely opening the door to a strong stream of revenue. So, it’s not surprising to see that investors are continuing the excitement surrounding the stock today. As is just about always the case, our partners at Trade Ideas were the first to alert us to the gains. Currently (11:09), MYOS is trading at $1.62 per share after a gain of $0.19 per share or 13.06% thus far today.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the iWatch Markets team will continue to keep a close eye on MYOS. In particular, we’re interested in following the story surrounding the company’s sales of its newly launched Yolked product. Nonetheless, we’ll continue to follow the news closely and bring it to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the iWatch Markets mailing list below!

Subscribe Today!

* indicates required


LEAVE A REPLY

Please enter your comment!
Please enter your name here